KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Debt Ratio: 2017-2024

Historic Debt Ratio for Aquestive Therapeutics (AQST) over the last 8 years, with Dec 2024 value amounting to 0.32.

  • Aquestive Therapeutics' Debt Ratio fell 22.05% to 0.22 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.88, marking a year-over-year increase of 209.99%. This contributed to the annual value of 0.32 for FY2024, which is 33.11% down from last year.
  • Per Aquestive Therapeutics' latest filing, its Debt Ratio stood at 0.32 for FY2024, which was down 33.11% from 0.48 recorded in FY2023.
  • In the past 5 years, Aquestive Therapeutics' Debt Ratio registered a high of 0.91 during FY2022, and its lowest value of 0.32 during FY2024.
  • For the 3-year period, Aquestive Therapeutics' Debt Ratio averaged around 0.57, with its median value being 0.48 (2023).
  • Per our database at Business Quant, Aquestive Therapeutics' Debt Ratio spiked by 47.26% in 2021 and then slumped by 47.53% in 2023.
  • Over the past 5 years, Aquestive Therapeutics' Debt Ratio (Yearly) stood at 0.59 in 2020, then surged by 47.26% to 0.86 in 2021, then rose by 5.73% to 0.91 in 2022, then crashed by 47.53% to 0.48 in 2023, then tumbled by 33.11% to 0.32 in 2024.